FOX Translator
No data currently available.
No data currently available.
In the wide and varied family of the thousands and thousands of funds out there, the exchange-traded fund is one of the more consumer-friendly ones.
Unlike mutual funds, exchange-traded funds, or ETFs, behave more like stocks. You can buy
into an ETF at any time, and sell it whenever you feel like it. And like a stock, an ETF's value can rise and fall--depending
on what the ETF is invested in.What do ETFs invest in? Well, they're typically linked to an index like the Dow Jones Industrial
Average or the S&P 500. So, if you had an ETF that trades the same companies that make up the Dow or the S&P, it will
rise and fall in value pretty much the same amount as the Dow or S&P.
You can also buy ETFs that invest in other
types of products, like bonds, currencies, gold or other commodities. The ETF market has grown considerably in the past few
years, so there is no shortage of ETFs to invest in.
Home / Markets / Industries / Health Care
Wednesday, May 14, 2008
NimbuDerm(TM) Receives Wound Healing Society's Prestigious Blue Ribbon Award
Comtex
GAINESVILLE, Fla., May 14, 2008 (BUSINESS WIRE) ----Quick-Med Technologies, Inc. is pleased to announce that a team of scientists from Quick-Med received the Blue Ribbon Award at the Symposium on Advanced Wound Care and Wound Healing Society's 21st Annual Meeting for the outstanding abstract entitled: "Persistent Skin Sanitizer (NimbuDerm(TM)) with Sustained Microbicidal Properties." The abstract was sponsored by Quick-Med Technologies and the University of Florida at Gainesville.
The Wound Healing Society offers the Blue Ribbon Industrial Research & Development Award to recognize the best product-oriented research performed by research and development scientists within the corporate world. This year, a total of 11 blue ribbons were awarded including 2 to teams from Quick-Med Technologies. Other participants at the SAWC/WHS event were prominent companies such as Johnson & Johnson Wound Management, 3M Healthcare, Kinetic Concepts, Inc., and Healthpoint, Ltd., as well as leading educational institutions such as the Harvard Medical School, Stanford University, and the University of Pennsylvania School of Medicine.
"We are honored to receive this important recognition from such a prestigious organization as the Wound Healing Society," said J. Ladd Greeno, CEO of Quick-Med Technologies. "NimbuDerm technology represents an important breakthrough that has the potential to dramatically improve hand hygiene by combining the power of an instant sanitizer with long-lasting personal protection."
This project team is lead by David Moore(1) and includes William Toreki(1), Roy Carr(1), Gregory Schultz(1,2), Christopher Batich(1,2), Albina Mikhaylova(1), Jillian Vella(1), and Gerald Olderman(1). ((1)Quick-Med Technologies, Inc.; (2)University of Florida)
Human use tests show that NimbuDerm is both instant and provides a high level of continuing antimicrobial protection for 6 hours after application without wearing off or losing its effectiveness. Poor hand hygiene is considered to be a major contributor to the spread of infectious diseases and the increase of potentially deadly methicillin-resistant Staphylococcus aureus, or MRSA infections.
NimbuDerm, an extension of Quick-Med's NIMBUS(R) technology, opens up new application vistas as a result of its liquid form, unique properties, and formulation flexibility.
The poster in its entirety can be accessed by clicking here.
About the Wound Healing Society
The Wound Healing Society is a non-profit organization composed of clinical and basic scientists. The Society provides a forum for interaction among scientists, physicians, licensed practitioners, industrial representatives and government agencies. Founded in 1990, the Society is recognized among professionals and government agencies as the leading scientific organization focused in this area of wound healing. The Society publishes the leading journal in this area, Wound Repair and Regeneration.
About Quick-Med Technologies, Inc.
Quick-Med Technologies, Inc. is a life sciences company that is developing innovative technologies for the healthcare and consumer markets. For more information, see: www.quickmedtech.com.
(C) 2008 Quick-Med Technologies, Inc. All rights reserved. NIMBUS(R) is a registered trademark and NimbuDerm(TM) is a trademark of Quick-Med Technologies, Inc.
Forward-looking statements (statements which are not historical facts) in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. For this purpose, any statements contained in this release that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as "may", "will", "to," "expect," "plan," "believe," "anticipate," "intend," "could," "would," "estimate," and/or "continue" or the negative or other variations thereof or comparable terminology is intended to identify forward-looking statements involve risks and uncertainties, including those risks that are discussed in the Company's filings with the Securities and Exchange Commission ("SEC"), which may be accessed at the SEC's Edgar System at www.sec.gov.
SOURCE: Quick-Med Technologies, Inc.
Quick-Med Technologies, Inc. Investor & Media Relations: Natasha A. Sorobey, 888-835-2211, ext. 107 info@quickmedtech.com
Copyright Business Wire 2008
Market Snapshot
| Symbol | Last Price | Netchange | Volume |
|---|---|---|---|
| -- | -- | -- | -- |
| -- | -- | -- | -- |
| -- | -- | -- | -- |
| -- | -- | -- | -- |
| -- | -- | -- | -- |
